Similar Articles
1711 Activins and activin antagonists in hepatocellular carcinoma
1712 Current role of ultrasound for the management of hepatocellular carcinoma
1713 Tumor suppressor and hepatocellular carcinoma
1714 Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma
1715 DNA methylation in hepatocellular carcinoma
1716 Apoptosis of human pancreatic cancer cells induced by Triptolide
1717 High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis
1718 Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma
1719 COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma
1720 Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA